Alzheimer disease (AD), the most common form of dementia, is a progressive disorder. The histopathological hallmarks of AD begin decades prior to its clinical expression
1,2; a recent study estimated that amyloid-β deposits form over a period of more than 2 decades.
3 The long preclinical phase of dementia has implications for the timing of interventions. There is growing consensus that interventions should target the earliest possible phase, perhaps the asymptomatic stage,
4,5 to be effective. The other major implication, which has received less attention to date, is the analytic framework used to identify putative risk factors for dementia. When measured in the years immediately prior to dementia diagnosis, these factors are likely to reflect common causes, the effects of preclinical disease (reverse causation), or prodromal changes rather than risk factors for dementia.